Mutant calreticulin for the diagnosis of myeloid malignancies Grant US-11274350-B2 United States of America 15 Mar 2022
ANTI-TRUNCATED MUTANT CALR-CD3 BISPECIFIC ANTIBODY AND PHARMACEUTICAL COMPOSITION Application WO-2022045247-A1 World Intellectual Property Organisation (WIPO) 03 Mar 2022
ANTIBODY CAPABLE OF BINDING TO TRUNCATED MUTANT CALRETICULIN, AND DIAGNOSTIC… Application WO-2020175689-A1 World Intellectual Property Organisation (WIPO) 03 Sep 2020
MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF Application WO-2020172601-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020